TBX2, a T-box family TF, has been shown to induce EMT (reduced E-cadherin, increased N-cadherin) and WNT signaling, resulting in enhanced metastasis in prostate cancer models (Du et al., 2017, Nandana et al., 2017). Here, TBX2 is linked to prostate cancer.